公司概覽
業務類別 Biotechnology
業務概覽 Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
公司地址 500 North Beacon Street, 4th Floor, Watertown, MA, USA, 02472
電話號碼 +1 857 285-5300
傳真號碼 --
公司網頁 https://www.kymeratx.com
員工數量 238
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Brian R. Adams Chief Legal Officer and Corporate Secretary -- 03/09/2025
Dr. Nello Mainolfi, PhD Director, Chief Executive Officer and President 美元 670.00K 26/02/2026
Mr. Bruce Jacobs, C.F.A.,M.B.A. Chief Financial Officer and Principal Accounting Officer 美元 481.00K 26/02/2026
Dr. Jared Gollob, M.D. Chief Medical Officer 美元 490.00K 29/04/2025
Mr. Noah Goodman, M.B.A. Chief Business Officer -- 29/04/2025
Dr. Jeremy G. Chadwick,PhD Chief Operating Officer 美元 490.00K 29/04/2025
 
董事會成員
董事會 職務 更新日期
Dr. John M. Maraganore,PhD Independent Director 26/02/2026
Mr. Jeffrey W. Albers, J.D.,M.B.A. Independent Director 26/02/2026
Dr. Bruce Booth, D.Phil. Chairman of the Board 26/02/2026
Ms. Elena H. Ridloff, C.F.A. Independent Director 26/02/2026
Dr. Victor Sandor, C.M.,PhD Independent Director 26/02/2026
Dr. Pamela Esposito, PhD Independent Director 26/02/2026
Dr. Nello Mainolfi, PhD Director, Chief Executive Officer and President 26/02/2026
Dr. Gorjan Hrustanovic, PhD Independent Director 26/02/2026
Dr. Felix J. Baker, PhD Lead Independent Director 26/02/2026
 
所屬ETF (更新日期: 07/03/2026 02:53)
代號 名稱 佔比% 持有日期
WSMLiShares MSCI World Small-Cap ETF0.005%28/02/2026
GSSCGoldman Sachs ActiveBeta® US SmCp Eq ETF0.004%27/02/2026
UWMProShares Ultra Russell20000.004%27/02/2026
URTYProShares UltraPro Russell20000.004%27/02/2026
BIBProShares Ultra Nasdaq Biotechnology0.004%27/02/2026
BBCVirtus LifeSci Biotech Clinical Trls ETF0.004%27/02/2026
MMSCFirst Trust Multi-Manager Sm Cp Opps ETF0.004%26/02/2026
TILTFlexShares Mstar US Mkt Factors Tilt ETF0.004%27/02/2026
OMFSInvesco Russell 2000® Dynamic Mltfct ETF0.003%27/02/2026
ITWOProShares Russell 2000 High Income ETF0.003%27/02/2026
ISCBiShares Morningstar Small-Cap ETF0.003%28/02/2026
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF0.003%28/02/2026
BKSEBNY Mellon US Small Cap Core Equity ETF0.002%28/02/2026
SPGMState Street® SPDR® Ptf MSCIGlbStkMktETF0.002%27/02/2026
RUSCRussell Inv U.S. Small Cap Equity ETF0.002%28/02/2026
TMEDT. Rowe Price Health Care ETF0.002%28/02/2026
RFLRInnovator U.S. Small Cp Mgd Flr ETF0.001%25/02/2026
ESSCEventide Small Cap ETF0.001%27/02/2026
DXUVDimensional US Vector Equity ETF0.001%27/02/2026
TNXTT. Rowe Price Innovation Leaders ETF0.001%28/02/2026
  1    2   3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.